UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046641
Receipt number R000053205
Scientific Title Study of the inhibitory effect on salt absorption by low doses intake of supplements
Date of disclosure of the study information 2022/01/14
Last modified on 2022/07/15 14:33:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the inhibitory effect on salt absorption by low doses intake of supplements

Acronym

Study of the inhibitory effect on salt absorption by low doses intake of supplements

Scientific Title

Study of the inhibitory effect on salt absorption by low doses intake of supplements

Scientific Title:Acronym

Study of the inhibitory effect on salt absorption by low doses intake of supplements

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the inhibitory effect on salt absorption for Japanese men (20 to 64 years old) when ingest the salt removal supplement for 4 days.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amount of urinary sodium

Key secondary outcomes

Amount of urinary potassium and urinary creatinine


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingest 3 tablets of the test food in the first test and 3 tablets of placebo in the second test, once a day for 4 days. Ingest the prescribed food during each intake period and the previous 3 days.

Interventions/Control_2

Ingest 3 tablets of placebo in the first test and 3 tablets of the test food in the second test, once a day for 4 days. Ingest the prescribed food during each intake period and the previous 3 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male

Key inclusion criteria

1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Healthy Japanese who are 20 years old or more and under 65 years old

Key exclusion criteria

1. Persons who have chronic illness, receiving medication, have a serious disease history
2. Persons who have been diagnosed with hypertension by a doctor
3. Persons who are allergic to foods
4. Persons who regularly take large amounts of the test food
5. Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect the absorption or discharge of salt
6. Persons who have a drinking habit (more than 3 days a week, 1 go or more in terms of sake per drinking day)
7. Persons with a BMI of less than 18.5 or 30 or more
8. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
9. Persons who were judged as inappropriate for study participants by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

masudat@hc-sys.jp


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

masudat@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

TOY MEDICAL Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 01 Month 07 Day

Date of IRB

2022 Year 01 Month 07 Day

Anticipated trial start date

2022 Year 02 Month 05 Day

Last follow-up date

2022 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 14 Day

Last modified on

2022 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053205


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name